Hao Zeng
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 6
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 8
- Cancer, Lipids, and Metabolism 7
- Cancer Genomics and Diagnostics 6
- Molecular Biology top 10%
- Renal and related cancers 11
-
- Prostate Cancer Treatment and Research 30
- Prostate Cancer Diagnosis and Treatment 15
- Renal cell carcinoma treatment 13
- Co-authors
- Gary D. KruhMartin G. BelinskyZhe‐Sheng ChenPhilip A. ReaKun Hee LeeQiao ZhouXueqin ChenIrina Shchaveleva
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Hao Zeng
104 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 122
- Oncology 1.1k
- Cancer Research 504
- Pediatrics, Perinatology and Child Health 404
- Molecular Biology 922
- Pulmonary and Respiratory Medicine 429
Countries citing papers authored by Hao Zeng
This map shows the geographic impact of Hao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Zeng more than expected).
Fields of papers citing papers by Hao Zeng
This network shows the impact of papers produced by Hao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Zeng. The network helps show where Hao Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hao Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 7 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 1 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 17 | |
| 16 | 2017 | 5 | |
| 17 | 2010 | 13 | |
| 18 | Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). | 2002 | 201 |
| 19 | 2001 | 129 | |
| 20 | Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. | 1999 | 137 |
About Hao Zeng
Hao Zeng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 117 papers that have together received 2.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (30 papers), Prostate Cancer Diagnosis and Treatment (15 papers), Renal cell carcinoma treatment (13 papers), Renal and related cancers (11 papers), Cancer-related molecular mechanisms research (8 papers), Cancer, Lipids, and Metabolism (7 papers), Cancer Genomics and Diagnostics (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (504 citations) and Pediatrics, Perinatology and Child Health (404 citations). Hao Zeng has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Gary D. Kruh, Martin G. Belinsky, Zhe‐Sheng Chen, Philip A. Rea, Kun Hee Lee, Qiao Zhou, Xueqin Chen, Irina Shchaveleva, Rebecca B. Raftogianis and Susan Walther.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.